scholarly journals 1049. Minimal Transient HIV-1 Viremia Following Vaccination Regimens Containing AD26. ZEBOV and MVA-BN-Filo in ART-Suppressed People Living with HIV

2021 ◽  
Vol 8 (Supplement_1) ◽  
pp. S616-S616
Author(s):  
Benjamin L Custer ◽  
Betty Mwesigwa ◽  
Fredrick Sawe ◽  
Janet Oyieko ◽  
Nyanda Ntinginya ◽  
...  
Keyword(s):  
Ebola Virus ◽  
Virus Disease ◽  
Sub Saharan Africa ◽  
People Living With Hiv ◽  
Virologic Suppression ◽  
Post Injection ◽  
Hiv Viral Load ◽  
Post Dose ◽  
The Mean ◽  
Placebo Recipients

Abstract Background Ebola Virus Disease (EVD) outbreaks primarily occur in the HIV endemic setting of Sub-Saharan Africa. Transient increases in HIV viral load (VL), or blips, have been described following routine vaccinations. We characterized VL blips among PLWH enrolled in a phase 2 trial of a heterologous two-dose EVD vaccine. Methods In EBL2003, adult participants with and without HIV were randomized 1:4 to receive placebo or vaccine. Part A in the US studied MVA-BN-Filo followed by Ad26.ZEBOV 14 days later. Part B in Africa evaluated this MVA/Ad26 regimen and also a schedule of Ad26.ZEBOV followed by MVA-BN-Filo 29 days later. VL was assessed at screening, pre-vaccination, and 21, 42, 180, and 365 days post dose 2. Participants with VL < 20 copies/mL at the first 2 visits who received both doses and had complete VL data through 42 days post dose 2 were evaluated. Blips were defined as a post-injection VL ≥ 20 copies/mL no later than 42 days post dose 2, with subsequent return to VL < 20 copies/mL. Results A total of 277 PLWH on antiretroviral therapy (ART) were assessed; 73.3% (203) had baseline virologic suppression, and 89.2% (181) of those received both doses with complete VL data for inclusion in the analysis. Overall, 19.9% (36) experienced blips: 20.0% (29) of vaccinees vs 19.4% (7) of placebo recipients (p=1.0). All baseline suppressed participants with post-injection viremia subsequently regained suppression. Among vaccinees, the mean blip VL was 192 copies/mL, and the mean blip duration was 56 days, which was not significantly different from placebo. Of all blips, only 2 were > 1,000 copies/mL. Blips occurred in 24.0% (25) of Ad26/MVA recipients, and 9.7% (4) of MVA/Ad26 recipients (p=0.07). A dose of Ad26 was associated with a blip in 6.9% (10) of recipients vs 13.1% (19) for MVA recipients (p=0.12). Regardless of regimen, dose 1 was associated with a blip in 8.3% (12) of vaccinees, compared to 11.7% (17) of vaccinees for dose 2 (p=0.43). Conclusion Among successfully treated PLWH, we observed low magnitude post-dose HIV blips that were not more common in vaccine vs. placebo recipients and did not result in loss of virologic suppression. This data is favorable for the deployment of the EVD vaccines in this trial in areas of high HIV endemicity. Disclosures Benjamin L. Custer, M.D., Alexion Pharmaceuticals (Shareholder)Armata Pharmaceuticals (Shareholder)Biomarin Pharmaceutical (Shareholder)Crispr Therapeutics (Shareholder)CVS Health Corp (Shareholder)Editas Medicine (Shareholder)Gilead (Shareholder)Glaxo Smith Kline (Shareholder)Hologic Inc (Shareholder)Merck (Shareholder)Mesoblast LTD (Shareholder)Pfizer (Shareholder)Sanofi (Shareholder)Unitedhealth Group (Shareholder)Vertex Pharmaceuticals (Shareholder) Georgi Shukarev, MD, Janssen (Employee) Auguste Gaddah, PhD, Janssen Pharmaceutica N.V (Employee) Kerstin Luhn, PhD, Janssen Vaccines and Prevention (Employee, Shareholder) Macaya Douoguih, MD, MPH, Janssen (Employee) Cynthia Robinson, MD, Janssen Vaccines (Employee)

scholarly journals RISK FACTORS FOR THE DEVELOPMENT OF NON-HODGKIN’S LYMPHOMA IN PATIENTS WITH HIV AND HEPATITIS С COINFECTION

2013 ◽  
Vol 18 (5) ◽  
pp. 4-8
Author(s):  
E. L Melnikova ◽  
E. V Volchkova ◽  
E. V Ivannikov ◽  
A. Ya Olshansky ◽  
V. N Vdovina ◽  
...  
Keyword(s):  
Risk Factors ◽  
Viral Load ◽  
Cell Count ◽  
Hodgkin's Lymphoma ◽  
Virologic Suppression ◽  
Hiv Viral Load ◽  
Cd4 Cell Count ◽  
The Mean ◽  
Hcv Coinfection ◽  
Cd4 Cell

The objective of the study was to investigate risk factors for the development of non-Hodgkin's lymphoma (NHL) in HIV-infected patients with hepatitis С virus (HCV) coinfection. A total of 37 HIV-positive subjects with NHL treated in the Moscow Center for Prevention and Control of AIDS between 2009 and 2013 were included in the study. HIV patients were divided into 2 groups: 23 cases with HCV coinfection and 14 patients without HCV coinfection. At the time of making the diagnosis of NHL 90% of patients had CD4 cell count < 350 cell/mm 3. The mean CD4 cell count in the first group (120±123 cell/mm 3) was significantly lower (p=0,035), than in patients without HCV coinfection (267±253 cell/mm3). At the time of making the diagnosis of NHL 70% of patients had HIV viral load ≥5,00 log10. The mean viral load was 5,47±1,09 log10 copies/ml in the first group and 4,06±2,03 log10 copies/ml in the second group (p=0,033). At the time of making the diagnosis of NHL 78% of patients did not receive combination antiretroviral therapy (cART). In most patients who received cART virologic suppression unsufficient and CD4 cell count remained to be low. Risk factors associated with an increased risk of NHL in HIV-infected patients with HCV coinfection are low CD4 cell count, high HIV viral load and lack of effective cART. Timely initiation of cART followed by complete virologic suppression and CD4 recovery are key factors to prevent NHL in HIV-infected patients.

scholarly journals COVID-19 Response in Sub-Saharan Africa: Lessons From Uganda

2020 ◽  
Vol 14 (3) ◽  
pp. e46-e48 ◽  
Author(s):  
Ivan Lumu
Keyword(s):  
Decision Making ◽  
Ebola Virus ◽  
Virus Disease ◽  
Sub Saharan Africa ◽  
Disease Spread ◽  
East African ◽  
Limited Disease ◽  
African Countries ◽  
Response Team ◽  
Sub Saharan

ABSTRACTThe prolongation of the Ebola epidemic may have allowed some countries to prepare and respond to the coronavirus disease (COVID-19) outbreak. In Uganda, the surveillance structure built for Ebola virus disease (EVD) has become a pillar in the COVID-19 response. This testing and tracing apparatus has limited disease spread to clusters with zero mortality compared with the neighboring East African countries. As more sub-Saharan countries implement social distancing to contain the outbreak, the interventions should be phased and balanced with health risk and socioeconomic situation. However, having a decision-making matrix would better guide the response team. These initial lessons from EVD-experienced Uganda may be helpful to other countries in the region.

scholarly journals Pre-Ebola virus disease laboratory system and related challenges in Liberia

2016 ◽  
Vol 5 (3) ◽  
Author(s):  
Stephen B. Kennedy ◽  
John B. Dogba ◽  
Christine L. Wasunna ◽  
Philip Sahr ◽  
Candace B. Eastman ◽  
...  
Keyword(s):  
Infectious Diseases ◽  
Ebola Virus ◽  
Virus Disease ◽  
Emerging Infectious Diseases ◽  
Health Facilities ◽  
Sub Saharan Africa ◽  
Ebola Virus Disease ◽  
Reference Laboratory ◽  
Laboratory System ◽  
Human Resource Capacity

Prior to the Ebola virus disease outbreak in Liberia, the laboratory system was duplicativefragmented and minimally coordinated. The National Reference Laboratory was conceptualisedto address the existing challenges by promoting the implementation of effective and sustainablelaboratory services in Liberia. However, in a resource-limited environment such as Liberiaprogress regarding the rebuilding of the health system can be relatively slow, while efforts tosustain the transient gains remain a key challenge for the Ministry of Health. In this paper, wedescribe the pre-Ebola virus disease laboratory system in Liberia and its prevailing efforts toaddress future emerging infectious diseases, as well as current Infectious diseases, all of whichare exacerbated by poverty. We conclude that laboratory and diagnostic services in Liberiahave encountered numerous challenges regarding its efforts to strengthen the healthcaredelivery system. These challenges include limited trained human resource capacity, inadequateinfrastructure, and a lack of coordination. As with most countries in sub-Saharan Africa, whencomparing urban and rural settings, diagnostic and clinical services are generally skewedtoward urban health facilities and private, faith-based health facilities. We recommend thatstructured policy be directed at these challenges for national institutions to develop guidelinesto improve, strengthen and sustain diagnostic and curative laboratory services to effectivelyaddress current infectious diseases and prepare for future emerging and re-emerging infectiousdiseases.

Awareness and Education on Viral Infections in Nigeria Using Edutainment

2017 ◽  
pp. 245-260
Author(s):  
Suleimanu Usaini ◽  
Tolulope Kayode-Adedeji ◽  
Olufunke Omole ◽  
Tunji Oyedepo
Keyword(s):  
Ebola Virus ◽  
Viral Infections ◽  
Virus Disease ◽  
Medical Science ◽  
Sub Saharan Africa ◽  
Immunodeficiency Virus ◽  
Public Health Challenge ◽  
Sub Saharan ◽  
Hepatitis C Viruses ◽  
Means Of Transmission

Researches in clinical and medical science have shown that Human Immunodeficiency Virus (HIV), Hepatitis B, and to some extent Hepatitis C viruses, constitute a major public health challenge in the Sub-Saharan Africa. This is without prejudice to the Ebola virus disease (EVD) that is more deadly than the other three put together, and had affected some countries in West Africa- Liberia, Sierra Leone and Guinea. There is little awareness and education via the mass media on some common viral infections in Nigeria like Hepatitis compared to HIV. Therefore, there is dire need for information, sensitisation and education on the viruses, means of transmission, preventive measures and also therapy. Edutainment is the fusion of education into entertainment programming which can come in form of drama, music, poetry and lots more, and it had been used as a platform to create awareness for positive reproductive health and HIV/AIDS by leading health organisations like WHO, USAID, DFID, SFH, and UNFPA. This paper therefore, examines why edutainment should be used and how it can be used to educate media audience in Nigeria on some viral infections that pose serious health risks and how they can live healthy lives.

Viral Haemorrhagic Fevers and Malaria Co-Infections Among Febrile Patients Seeking Health Care in Tanzania

2021 ◽  
Author(s):  
Sima Rugarabamu ◽  
Susan F. Rumisha ◽  
Gaspary O. Mwanyika ◽  
Calvin Sindato ◽  
Hee-Young Lim ◽  
...  
Keyword(s):  
Health Care ◽  
Ebola Virus ◽  
Virus Disease ◽  
Marburg Virus ◽  
Immunoglobulin M ◽  
Sub Saharan Africa ◽  
Infection Prevalence ◽  
Haemorrhagic Fever ◽  
Rapid Diagnostics ◽  
Valley Fever

Abstract Background: In recent years there have been reports of viral haemorrhagic fever (VHF) epidemics in Sub-Saharan Africa where malaria is endemic. VHF and malaria have overlapping clinical presentations making differential diagnosis a challenge. The objective of this study was to determine the prevalence of selected zoonotic VHFs and malaria co-infections among febrile patients seeking health care in Tanzania. Methods: This facility-based cross-section study was carried out in Buhigwe, Kalambo, Kyela, Kilindi, Kinondoni, Kondoa, Mvomero, and Ukerewe districts in Tanzania. The study involved febrile patients seeking health care from primary healthcare facilities. Blood samples were collected and tested for infections due to malaria, Crimean-Congo haemorrhagic fever (CCHF), Ebola virus disease (EVD), Marburg virus disease (MVD), Rift Valley fever (RVF) and yellow fever (YF). Malaria infections were tested using rapid diagnostics tests while exposure to VHFs was determined by screening for immunoglobulin M antibodies using commercial enzyme-linked immunosorbent assays. Results: A total of 308 participants (mean age=35±18.9 years) were involved in the study. Of these, 54 (17.5%) had malaria infection and 15 (4.8%) were positive for IgM antibodies against VHFs (RVF=8; CCHF=2; EBV=3; MBV=1; YF=1). Six (1.9%) individuals had both VHF (RVF=2; CCHF=1; EVD=2; MVD=1) and malaria infections. The highest co-infection prevalence (0.6%), was observed among individuals aged 46-60 years (p<0.05). District was significantly associated with co-infection (p<0.05) with the highest prevalence recorded in Buhigwe (1.2%) followed by Kinondoni (0.9%) districts. Headache (100%) and muscle, bone, back and joint pains (83.3%) were the most significant complaints among those infected with both VHFs and malaria (p=0.001). Conclusions: Co-infections of VHF and malaria are prevalent in Tanzania and affect more the older than the younger population. Since the overlapping symptoms in co-infected individuals may challenge accurate diagnosis, adequate laboratory diagnosis should be emphasized in the management of febrile illnesses.

scholarly journals Biosafety level-2 laboratory diagnosis of Zaire Ebola virus disease imported from Liberia to Nigeria

2016 ◽  
Vol 5 (1) ◽  
Author(s):  
Olumuyiwa B. Salu ◽  
Ayorinde B. James ◽  
Bamidele O. Oke ◽  
Mercy R. Orenolu ◽  
Roosevelt A. Anyanwu ◽  
...  
Keyword(s):  
Ebola Virus ◽  
Virus Disease ◽  
Rna Extraction ◽  
Molecular Techniques ◽  
Viral Rna ◽  
Sub Saharan Africa ◽  
Ebola Virus Disease ◽  
Rt Pcr ◽  
Route Of Transmission ◽  
Biosafety Level

Introduction: Global travel is an efficient route of transmission for highly infectious pathogens and increases the chances of such pathogens moving from high disease-endemic areas to new regions. We describe the rapid and safe identification of the first imported case of Ebola virus disease in a traveler to Lagos, Nigeria, using conventional reverse transcription polymerase chain reaction (RT-PCR) in a biosafety level (BSL)-2 facility.Case presentation: On 20 July 2014, a traveler arrived from Liberia at Lagos International Airport and was admitted to a private hospital in Lagos, with clinical suspicion of Ebola virus disease.Methodology and Outcome: Blood and urine specimens were collected, transported to the Virology Unit Laboratory at the College of Medicine, University of Lagos, and processed under stringent biosafety conditions for viral RNA extraction. RT-PCR was set-up to query the Ebola, Lassa and Dengue fever viruses. Amplicons for pan-filoviruses were detected as 300 bp bands on a 1.5% agarose gel image; there were no detectable bands for Lassa and Dengue viral RNA. Nucleotide BLAST and phylogenetic analysis of sequence data of the RNA-dependent RNA polymerase (L) gene confirmed the sequence to be Zaire ebolavirus (EBOV/Hsap/ NGA/2014/LIB-NIG 01072014; Genbank: KM251803.1).Conclusion: Our BSL-2 facility in Lagos, Nigeria, was able to safely detect Ebola virus disease using molecular techniques, supporting the reliability of molecular detection of highly infectious viral pathogens under stringent safety guidelines in BSL-2 laboratories. This is a significant lesson for the many under-facilitated laboratories in resource-limited settings, as is predominantly found in sub-Saharan Africa.

Awareness and Education on Viral Infections in Nigeria Using Edutainment

2020 ◽  
pp. 699-714
Author(s):  
Suleimanu Usaini ◽  
Tolulope Kayode-Adedeji ◽  
Olufunke Omole ◽  
Tunji Oyedepo
Keyword(s):  
Ebola Virus ◽  
Viral Infections ◽  
Virus Disease ◽  
Medical Science ◽  
Sub Saharan Africa ◽  
Immunodeficiency Virus ◽  
Public Health Challenge ◽  
Sub Saharan ◽  
Hepatitis C Viruses ◽  
Means Of Transmission

Researches in clinical and medical science have shown that Human Immunodeficiency Virus (HIV), Hepatitis B, and to some extent Hepatitis C viruses, constitute a major public health challenge in the Sub-Saharan Africa. This is without prejudice to the Ebola virus disease (EVD) that is more deadly than the other three put together, and had affected some countries in West Africa- Liberia, Sierra Leone and Guinea. There is little awareness and education via the mass media on some common viral infections in Nigeria like Hepatitis compared to HIV. Therefore, there is dire need for information, sensitisation and education on the viruses, means of transmission, preventive measures and also therapy. Edutainment is the fusion of education into entertainment programming which can come in form of drama, music, poetry and lots more, and it had been used as a platform to create awareness for positive reproductive health and HIV/AIDS by leading health organisations like WHO, USAID, DFID, SFH, and UNFPA. This paper therefore, examines why edutainment should be used and how it can be used to educate media audience in Nigeria on some viral infections that pose serious health risks and how they can live healthy lives.

Sign in / Sign up

Export Citation Format

Share Document